Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising results. However, the price of this innovative drug and its availability have become key topics for patients and healthcare professionals. While tirzepatide has been authorized by regulatory agencies, its costly nature presents a significant barrier to m